INMED PHARMACEUTICALS INC. Short-term Debt
INMED PHARMACEUTICALS INC. (INM) had Short-term Debt of $29.31 thousand as of 2022-03-31, per its 10-Q filed 2022-05-13.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ShortTermBorrowings · last filed 2022-05-13
- 2022-03-31: Short-term Debt $29.31K.
- 2021-12-31: Short-term Debt $58.62K.
| Period end | Short-term Debt |
|---|---|
| 2022-03-31 | $29.31K 10-Q · filed 2022-05-13 |
| 2021-12-31 | $58.62K 10-Q · filed 2022-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |